Capital Xchange Forum
Where Capital Shapes the Future of Healthcare
26-29 October 2026
Riyadh Exhibition and Convention Center (Malham)
SCALING HEALTHCARE IMPACT THROUGH INNOVATION & CAPITAL
The Capital Xchange Forum is the thought-leadership platform of the Capital Xchange Programme, designed to convene the key players shaping healthcare investment in Saudi Arabia and beyond. Through a curated agenda of talks and panel discussions, the forum examines capital flows, emerging healthcare opportunities, innovation transfer, ecosystem readiness and the role of government in unlocking investment at scale.
From identifying the next major capital movers to addressing gaps in healthcare delivery, policy and investability, the forum creates a platform for meaningful dialogue on how healthcare systems, investors and institutions can work together to turn opportunity into real market outcomes.
Capital Inflow & Emerging Space
Identifying the Capital Movers in Healthcare
Opportunities in Healthcare Innovation and Funding
Showcasing Saudi Healthcare Innovation and Scaling New Ideas
WHAT’S NEW IN 2026
Closed Door Investor Roundtables
Private, high-trust conversations connecting investors with Saudi government stakeholders to explore investment opportunities, regulatory developments and strategic priorities.
Healthcare Ecosystem Highlights
A hands-on showcase of Saudi Arabia's major healthcare projects, national initiatives, R&D centers, and transformational ventures that are driving innovation and shaping the nation's healthcare landscape.
Expanded Investment Sectors
The forum now expands beyond emerging technologies to include primary care, infrastructure and services across the full healthcare value chain.
Power Breakfast Series
Curated morning sessions bringing together segmented investor groups for focused discussions and high level networking.
Reverse Pitches
A curated exchange where investors articulate strategic priorities and investment theses, and startups and scaleups respond with targeted solutions to generate more relevant deal flow.
Diversified Speaker Line-up
A diversified speaker lineup featuring a broader range of archetypes, including investors, unicorns showcasing their journeys, and policy-focused talks.
WHY ATTEND |
UNDERSTAND TRENDS ON HEALTHCARE INVESTMENT
Hear from top investors about emerging spaces and their impact on the market.
OPPORTUNITIES TO RAISE CAPITAL
Meet with allocators, funds and other investors understand their mandates and explore partnership opportunities.
UNDERSTAND THE BIOTECH BOOM
Understand the Boom in Biotech in the Kingdom and how it is shaping the global Biotech Investment Leadership.
MEET WITH GLOBAL INVESTMENT LEADERS
Insights from specialized investors, VCs, and major allocators, along with opportunities to connect directly with the investors shaping the global industry.
ENTER THE SAUDI MARKET WITH EASE
Engage with government entities like MISA, SFDA, and MOH, along with service providers, for seamless market entry into Saudi Arabia
PREVIOUS SPEAKERS
Dr Helmut Schuehsler
CEO & Chairman at TVM Capital Healthcare
Dr. Schuehsler is a pioneering investor and operator, shaping the global healthcare landscape. As Chairman & CEO of TVM Capital Healthcare, he has directed over $2B in global healthcare investments, building hospitals and care networks across the Middle East and Asia and establishing himself as one of the foremost voices in healthcare private equity.
Michael Gold
President of Civil and International Space at Redwire
Mike Gold is Redwire's President of Civil and International Space. Prior to joining Redwire, Mike led NASA's Office of International and Interagency Relations and was awarded NASA's Outstanding Leadership Medal for his work on the Artemis Accords.
Sami Yusuf
Chair of Business Development at Mayo Clinic
Dr Sami Yusuf serves as Chair of Corporate Development for International where he is responsible for driving partnerships, strategic collaborations and strategic alliances by coordinating, negotiating, and executing strategic transactions in support of Mayo Clinic and its International business.
Dr Anastasiia Natrova
Advisor (Biotech and Deep Tech) at Family offices (GCC, EU)
Dr Anastasiia Natrova is a medical doctor, neuroscientist, and biotech advisor to investors across the GCC and EU. She connects science, capital, regulation, and strategy to support biotech, longevity, and health innovation globally.
Mr. Lloyd Price
Partner at Nelson Advisors
Lloyd Price is a Partner at Nelson Advisors, one of Europe's leading HealthTech M&A Advisory Firms. Founded and Exited multiple HealthTech companies. Advisor for Oxford MedTech Society, Oxford VC Network and UCL Global Business School for Health.
Dr Yazeed Alsufyani
GP & CEO at IB Ventures
Dr. Yazeed Alsufyani, has led major healthcare funds and built transformative ventures like IV ONE and is launching the Biotech Focused Fund IB Ventures. At GHE, he will explore how scaling capital-backed healthcare models can accelerate Vision 2030 and talk about new investment vehicles supporting healthcare in KSA
Dr. Mussaad Al-Razouki
Operating Partner at Deerfield Management
Dr. Mussaad M. Al-Razouki is an Operating Partner at Deerfield Management and is the Chairman of Société Arabe Des Industries Pharmaceutiques (SAIPH) based in Tunis, Tunisia, Vice Chairman of ACDIMA based in Amman, Jordan
Mr. Christian Hein
Venture Partner & Executive Advisor - Healthtech & AI at Vorwerk Ventures
Christian Hein is a Venture Partner at Vorwerk Ventures. Previously VP of Digital Transformation at Novartis, he's led large scale AI deployments worldwide. He is an Executive Advisor to startups and large life science corporate on scaling AI.
Dr. Mohammad Khobreh
Managing Partner at NG Bio Ltd
Mohammad Khobreh is a biotech investor and entrepreneur leading life sciences investments for a family office. With over 30 investments and major exits, he brings deep expertise in therapeutics, drug discovery, and venture building.
Loretta TIOIELA
Founder and Managing Partner at Next Sequence
Loretta TIOIELA is the Founder & Managing Partner of Next Sequence, a new venture firm focusing on accelerating in companies building at the edge of AI and Biology. She is a technologist with more than 15 years of experience in Cloud and A.I. technologies. She has worked for major industry players such as Samsung Electronics and Huawei Technologies as well as startups.
Mr. Cédric Odje
Senior Associate at Debiopharm Innovation Fund
Cédric Odje is a venture investor and entrepreneur with extensive experience in biotech and oncology innovation. He has supported over 20 startups, serves on several boards, and is passionate about advancing global health and entrepreneurship.
Mr. Antoine D'Hollander
Investment Director at Capricorn Partners
Antoine D'Hollander is the Investment Director of Capricorn Healthtech Fund II. He specializes in investments in European digital and connected medtech companies. With his board representations in these companies, he assists them in navigating and scaling within the challenging healthcare market.
Roberta Marinelli
President and General Manager at Eli Lilly and Company
Roberta Marinelli is an accomplished senior executive with over two decades of international experience in the pharmaceutical and healthcare industries. She currently serves as President and General Manager for Lilly’s META region, based in Dubai.
GLIMPSES FROM THE 2025 FORUM
Media Partners
